MAFLD: What Is It?

Houston Methodist

D. Victor

Current Treatment of Metabolic Dysfunction Associated with Steatotic…

Indiana University School of Medicine Division of Gastroenterology and Hepatology

N. Samala

Acute Liver Failure Overview

UCSF School of Medicine

B. Hameed

Best Practices In Managing NAFLD / NASH

MedNews Week

D. Bernstein

The Fatty Liver Disease Epidemic

UPMC

M. Klinge

Alcoholism is a Mid-brain Disease: Treat it as Such

Houston Methodist

H. Wetsman

Hepatic Encephalopathy and Acute Liver Failure

Obafemi Awolowo University

O. Adekanle

Using Resmetirom (THR-β Agonist) in Your Practice for MASH

Scripps Health

J. Gutierrez

Panel Case Discussion: Acute Liver Failure Evaluation and Treatment

UCLA Health

G. Choi, A. Shetty, F. Kaldas, S. Saab

Liver Fat, Iron, Fibrosis, (and T1): Quantitative MRI in Chronic Liv…

UCSF School of Medicine

M. A. Ohliger

Evaluating Liver-Related Mortality and Liver Transplant Outcomes

Stanford Medicine

W. Ray Kim

Heart and Liver Interactions

Houston Methodist DeBakey Heart and Vascular Center

S. Adeel Ahsan

NASH Update 2023

Icahn School of Medicine at Mount Sinai

M. B. Bansal

Update on Hepatology Literature

UCLA Health

J. Benhammou, C. Wong

Cutting Edge Diagnostics and Treatment for NAFLD

Northwestern Medicine Gastroenterology

M. E. Rinella, L. Van Wagner

The Evolving Landscape of Non-Alcoholic Fatty Liver Disease (NAFLD) …

Cardiometabolic Health Congress (CMHC)

K. Cusi

Fatty Liver Disease: When to Refer?

Yale School of Medicine

NAFLD: Updates in Management

UChicago Medicine

M. E. Rinella

New Treatments for Steatotic Liver Disease (SLD): Are We There Yet?

University of Miami

S. A. Harrison

Managing (Non-malignant) Complications of Cirrhosis

Indiana University School of Medicine Division of Gastroenterology and Hepatology

M. Ghabril